Experience our brand-new learning platform with a faster dashboard,
better performance, live classes, current affairs, test series,
and many more exciting features.
World Leprosy Day (WLD) is celebrated on the last Sunday of January.
This international day is an opportunity to celebrate people who have experienced leprosy, raise awareness of the disease, and call for an end to leprosy-related stigma and discrimination.
In India, it is observed on 30th January every year, coinciding with the death anniversary of Mahatma Gandhi.
He was deeply committed to the cause of leprosy-affected persons.
The theme of World Leprosy Day 2023 is “Act Now. End Leprosy.” This year’s theme calls attention to three key messages:
Elimination is possible: We have the power and tools to stop transmission and defeat this disease.
Act now: We need the resources and commitment to end leprosy. Prioritize leprosy elimination.
Reach the unreached: Leprosy is preventable and treatable. Suffering from leprosy is needless.
About Leprosy
It is also known as Hansen’s disease and is a chronic infectious disease caused by Mycobacterium leprae.
The disease affects the skin, the peripheral nerves, mucosal surfaces of the upper respiratory tract and the eyes.
It is known to occur at all ages ranging from early childhood to old age. Leprosy is at least 4,000 years old, making it one of the oldest diseases known to humanity.
It is transmitted via droplets, from the nose and mouth, during close and frequent contact with untreated cases.
The disease is not spread through casual contact with a person who has leprosy like shaking hands or hugging, sharing meals or sitting next to each other.
Impacts: Left untreated, the disease may cause progressive and permanent disabilities.
It is reported from all six WHO Regions; the majority of annual new case detections are from South-East Asia.
It is a neglected tropical disease (NTD) which still occurs in more than 120 countries, with more than 200 000 new cases reported every year.
Treatment: It is a curabledisease.
The currently recommended treatment regimen consists of three drugs: dapsone, rifampicin and clofazimine.
The combination is referred to as multi-drug therapy (MDT).